Lawford Davies Denoon, 14A Clerkenwell Green, London, EC1R 0DP, UK.
Regen Med. 2011 Nov;6(6 Suppl):85-7. doi: 10.2217/rme.11.76.
On 10 March 2011, the Advocate General of the Court of Justice for the European Union issued an Opinion, which essentially recommended that certain inventions related to human embryonic stem cells should not be patentable. Since the publication of the Opinion, the case (Brüstle v. Greenpeace Case C-34/10) has generated a lot of commentary, including numerous articles and discussion in the UK parliment. This article will seek to summarize the case and discuss its practical ramifications.
2011 年 3 月 10 日，欧盟法院的法律顾问发表了一份意见，该意见实质上建议不应授予与人类胚胎干细胞相关的某些发明专利。自该意见公布以来，此案（Brüstle 诉绿色和平组织案，C-34/10）引起了广泛关注，包括在英国议会中的大量文章和讨论。本文将试图总结此案并讨论其实际影响。
